Status:
UNKNOWN
The Validity and Reliability of FIT-HaNSA in Breast Cancer Patients
Lead Sponsor:
Gazi University
Conditions:
Breast Cancer
FIT-HaNSA
Eligibility:
All Genders
18-65 years
Brief Summary
Breast cancer is the most common type of cancer among women and covers 25% of all cancers. After mastectomy and reconstruction, many patients develop various upper extremity complications such as join...
Eligibility Criteria
Inclusion
- Those whose treatments for breast cancer have been completed 18 years and over
Exclusion
- Have a history of upper extremity surgery, excluding breast cancer surgery Have a history of upper extremity trauma Those who have orthopedic, neurological, rheumatological or cognitive impairments that may interfere with the application of the test.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04795778
Start Date
February 1 2021
End Date
September 1 2022
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inci Ayas
Ankara, Turkey (Türkiye), 06560